Systemic administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse heptocellular carcinoma.

被引：0

作者：

Tatsumi, T ^{[1
]}

Miyagi, T ^{[1
]}

Jinushi, M ^{[1
]}

Sugimoto, Y ^{[1
]}

Kuzushita, N ^{[1
]}

Takehara, T ^{[1
]}

Kanto, T ^{[1
]}

Sasaki, Y ^{[1
]}

Hori, M ^{[1
]}

Hayashi, N ^{[1
]}

机构：

[1] Osaka Univ, Suita, Osaka, Japan

来源：

HEPATOLOGY | 2000年 / 32卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

154

引用

收藏

页码：201A / 201A

页数：1

相关论文

共 37 条

[31] Irradiation enhances tumor oriented gp96 expression which induces dendritic cell mediated systemic antitumor effect against mouse squamous cell carcinoma, SCCVII [J].

Akutsu, Yasunori ;

Matsubara, Hisahiro ;

Urashima, Tetsuro ;

Komatsu, Aki ;

Miyazawa, Yukimasa ;

Matsushita, Kazuyuki ;

Sakata, Haruhito ;

Nishimori, Takanori ;

Hoshino, Isamu ;

Yoneyama, Yasuo ;

Murakami, Kentaro ;

Ochiai, Takenori .

CANCER RESEARCH, 2006, 66 (08)

[32] Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+T-cell responses with a long-lived effector cell phenotype [J].

Hatami, Jasmin ;

Das, Krishna ;

Wolf, Leonie ;

Aufschnaiter, Andreas ;

Kimpel, Janine ;

Nolden, Tobias ;

Schreiber, Liesa-Marie ;

Mullauer, Brigitte ;

Podgorschek, Elke ;

Schwaiger, Theresa ;

Spiesschaert, Bart ;

Wollmann, Guido ;

Elbers, Knut ;

von Laer, Dorothee ;

Banki, Zoltan .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (08)

[33] Intratumoral recombinant human interleukin-12 administration in head and neck squamous (cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor [J].

van Herpen, CML ;

van der Laak, JAW ;

de Vries, IJM ;

van Krieken, JH ;

de Wilde, PC ;

Balvers, MGJ ;

Adema, GJ ;

De Mulder, PHM .

CLINICAL CANCER RESEARCH, 2005, 11 (05) :1899-1909

[34] Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12 [J].

Homma, S ;

Komita, H ;

Sagawa, Y ;

Ohno, T ;

Toda, G .

IMMUNOLOGY, 2005, 115 (04) :451-461

[35] Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction [J].

Sun, Si-Jia ;

Lai, Wing-Hon ;

Jiang, Yu ;

Zhen, Zhe ;

Wei, Rui ;

Lian, Qizhou ;

Liao, Song-Yan ;

Tse, Hung-Fat .

THERANOSTICS, 2021, 11 (04) :1641-1654

[36] Dendritic cells engineered to secrete interleukin-12 P70 when delivered into tumors results in the crosspriming of an expanded anti-tumor CD8+ T cell repertoire and therapeutic benefit [J].

Komita, Hideo ;

Storkus, Walter J. .

JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) :896-896

[37] Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines [J].

Bellone, Stefania ;

El-Sahwi, Karim ;

Cocco, Emiliano ;

Casagrande, Francesca ;

Cargnelutti, Marilisa ;

Palmieri, Michela ;

Bignotti, Eliana ;

Romani, Chiara ;

Silasi, Dan-Arin ;

Azodi, Masoud ;

Schwartz, Peter E. ;

Rutherford, Thomas J. ;

Pecorelli, Sergio ;

Santin, Alessandro D. .

JOURNAL OF VIROLOGY, 2009, 83 (13) :6779-6789

← 1 2 3 4 →